Willmann, S., Marostica, E., Snelder, N., Solms, A., Jensen, M., Lobmeyer, M., . . . Bhanot, S. (2021). PK/PD modeling of FXI antisense oligonucleotides to bridge the dose‐FXI activity relation from healthy volunteers to end‐stage renal disease patients. Wiley.
Chicago Style (17th ed.) CitationWillmann, Stefan, et al. PK/PD Modeling of FXI Antisense Oligonucleotides to Bridge the Dose‐FXI Activity Relation from Healthy Volunteers to End‐stage Renal Disease Patients. Wiley, 2021.
MLA (8th ed.) CitationWillmann, Stefan, et al. PK/PD Modeling of FXI Antisense Oligonucleotides to Bridge the Dose‐FXI Activity Relation from Healthy Volunteers to End‐stage Renal Disease Patients. Wiley, 2021.
Warning: These citations may not always be 100% accurate.